Omer Aliyi | OMICS International
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Omer Aliyi


Problems of using Hydrochlorothiazide Diuretic in Adult Diabeti c Patient in Diabetic Clinic of Adama Hospital Medical College, E ast Shoa Zone, Oromia Regional State, Ethiopia

Background: Diabetes Mellitus (DM) is a group of common metabolic disorders that share the phenotype of hyperglycemia. Half century ago hydrochlorothiazide has been associated with a diagnosis of diabetes in hypertension treatment containing hydrochlorothiazide during long term therapy. This explained by association between glucose, potassium, and ... Read More»

Omer Aliyi, Mohammed Hussien and Belayneh Kefale

Research Article: Clin Pharmacol Biopharm 2015, 4:134

DOI: 10.4172/2167-065X.1000134

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF